2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
27
Lung Neoplasms
12
Neoplasms
5
Colorectal Neoplasms
5
Neoplasm Metastasis
4
Advanced Solid Tumors
3
Pancreatic Neoplasms
2
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
2
Venous Thromboembolism
1
Thoracic Neoplasms
1
Solid Tumor, Adult
1
Solid Tumor
1
Sexual Dysfunction, Physiological
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Ovarian Neoplasms
1
Noonan Syndrome
1
Non-small Cell Lung Cancer Metastatic
1
Non Small Lung Cancer
1
Neoplasms by Site
1
Mesothelioma
1
Lung Diseases
1
KRAS p.G12C Mutant Advanced Solid Tumors
1
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
1
Hereditary Sensory and Autonomic Neuropathies
1
Healthy Participants
1
Fallopian Tube Neoplasms
1
Eunuchism
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Interventions
Carboplatin
15
Pemetrexed
8
Paclitaxel
6
pembrolizumab
5
osimertinib
4
atezolizumab
4
Gemcitabine
4
Erlotinib Hydrochloride
4
entinostat
3
durvalumab
3
Cisplatin
3
selpercatinib
2
pralsetinib
2
camrelizumab
2
apatinib
2
Vinorelbine
2
Radiosurgery
2
Nivolumab
2
Injections
2
Gefitinib
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
toripalimab
1
taletrectinib
1
sotorasib
1
sintilimab
1
repotrectinib
1
pegylated granulocyte colony-stimulating factor
1
patritumab
1
necitumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
sotorasib
×
Clear all
NCT04959981
2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1
Completed
24 enrolled